Results 301 to 310 of about 231,012 (349)

Dexmedetomidine to Reduce Vasopressor Resistance in Refractory Septic Shock: α2 Agonist Dexmedetomidine for REfractory Septic Shock (ADRESS): A Double-Blind Randomized Controlled Pilot Trial. [PDF]

Crit Care Med
Dargent A, Bourredjem A, Jacquier M, Bohe J, Argaud L, Levy B, Fournel I, Cransac A, Badie J, Quintin L, Quenot JP.   +10 more
europepmc   +1 more source

Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation. [PDF]

Crit Care
White KC, Costa-Pinto R, Blank S, Whebell S, Quick L, Luke S, Attokaran AG, Garrett P, Ramanan M, Tabah A, Shekar K, Laupland KB, Kumar A, McCullough J, Udy A, Eastwood G, Bellomo R, Chaba A, Queensland Critical Care Research Network (QCCRN).   +18 more
europepmc   +1 more source

Optimizing Mean Arterial Pressure Targets for Septic Shock Patients With Chronic Hypertension: A Narrative Review. [PDF]

Health Sci Rep
Othman MI, Mustafa EM, Abdelwahab AE, Hssain AA, Nashwan AJ.   +4 more
europepmc   +1 more source

A comprehensive prognosis model for adult septic shock: SOFAplusCALLY index. [PDF]

Eur J Med Res
Lin X, Zhang L, Zheng Y, Hong X, Zheng H, Huang T, Ma J.   +6 more
europepmc   +1 more source

Corticosteroids in Pediatric Septic Shock: A Narrative Review. [PDF]

J Pers Med
Rulli I, Carcione AM, D'Amico F, Quartarone G, Chimenz R, Gitto E.   +5 more
europepmc   +1 more source

Severe and Rapid Progression of <i>Tropheryma whipplei</i>-Related Pneumonia With Septic Shock: A Case Report. [PDF]

Respirol Case Rep
Lv Y, Jiang G, Gao S, Wang H, Zhang Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Septic Shock

General Pharmacology: The Vascular System, 1998
1. Septic shock is still a major complication of patients in intensive care units (ICUs) and, therefore, a main goal of ICU-related research. 2. After the unsatisfying results of multicenter clinical trials in blocking proinflammatory mediators such as tumor necrosis factor and interleukin-1 or endotoxin itself, research has focused on other important ...
B, Klosterhalfen, R S, Bhardwaj
openaire   +4 more sources

Septic shock

The Lancet, 2005
Septic shock, the most severe complication of sepsis, is a deadly disease. In recent years, exciting advances have been made in the understanding of its pathophysiology and treatment. Pathogens, via their microbial-associated molecular patterns, trigger sequential intracellular events in immune cells, epithelium, endothelium, and the neuroendocrine ...
Djillali, Annane, Eric, Bellissant, Jean-Marc, Cavaillon   +2 more
openaire   +2 more sources